This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shandong Xinchuang Biological Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Feng Liu
Introduction: Feng Liu is an inventor based in Jinan, China. He is associated with Shandong Xinchuang Biological Technology Co., Ltd. Despite having no granted patents, Liu is actively involved in research and development in the field of biotechnology. His work focuses on the preparation of antigens and antibodies that serve as tumor markers.
Latest Patent Applications: One of Liu's notable patent applications is titled "Antigen and Antibodies Prepared Based on PADI4 Serving as Tumor Marker, and Application Thereof." This application discloses an antigen with an amino acid sequence shown as SEQ ID NO. 1. It also details specific antibodies prepared using the antigen. The protein PADI4 monoclonal antibodies include a protein PADI4 monoclonal antibody coated onto an ELISA plate and a biotin-labeled protein PADI4 monoclonal antibody. A kit prepared using these antibodies can effectively and stably determine the protein PADI4 level in human serum, showcasing broad spectrum detectability and high test repeatability.
Conclusion: Feng Liu's contributions to the field of biotechnology, particularly in the development of tumor markers, highlight his innovative spirit and dedication to advancing medical research. His work has the potential to impact diagnostic methods significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile